RE: Imm9 Dec 2025 16:36
Executing a pharmaceutical deal, such as a merger, acquisition, or significant licensing agreement, can take anywhere from six months to several years. The exact timeline depends heavily on the deal's complexity, regulatory requirements, and the integration needed.
The process involves several key phases, each with its own timeline:
Strategy and Target Identification: Developing a clear strategy and identifying the right target can take 1 to 3 months, or even longer (up to 2 years for identification).
Due Diligence: This critical phase involves verifying financial, legal, operational, and commercial aspects of the target company. It typically takes several months and can be a source of significant delays if unexpected issues arise.
Negotiating Terms: Finalizing the specifics of the deal, including valuation and purchase price, can take a few weeks to several months.